US Capitol Capsule: Cell-based, recombinant shots new plan of attack against H7N9
This article was originally published in Scrip
Unlike in 2009, when a new type of influenza began spreading worldwide, known as the H1N1 swine-origin influenza A virus, if the situation gets to the point in which immunization is necessary for A(H7N9), a novel strain of bird flu identified in China in late March – with the number of human cases growing from three to 21 within the first week of the initial reports to the World Health Organization (WHO) – in 2013, there are newer, quicker ways to make a vaccine.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.